VCN-01
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for VCN-01, covering 2024-08-27 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer [Phase 1]